Skip to content
2000
Volume 22, Issue 2
  • ISSN: 1573-3998
  • E-ISSN: 1875-6417
file format pdf download PDF
file format text download EPUB
side by side viewer icon HTML

Abstract

Introduction

FTO gene rs9939609, an obesity susceptible gene, has strong with type 2 diabetes mellitus (T2DM). Studies have also established an association between the FTO gene rs9939609 and cardiovascular disease (CVD). This research investigated the association of this genetic variant with microvascular and macrovascular complications related to diabetes.

Materials and Methods

We performed a cross-sectional analysis involving 140 participants with T2DM and 70 healthy control subjects. The DNA samples were analyzed for the FTO gene variant rs9939609 using ARMS-PCR. FTO gene association with diabetes-related microvascular and macrovascular complications was assessed through multivariate logistic regression, with unadjusted odds ratios (OR) and 95% confidence intervals. A -value below 0.05 was considered statistically significant.

Results and Discussion

The genotypic distribution of the FTO gene variant adhered to Hardy-Weinberg equilibrium in the study participants (>0.05). The AA genotype exhibited a robust association with elevated BMI, HbA1C, SBP, DBP, TGs and decreased HDL-C levels relative to the AT and TT genotypes with (=0.002). FTO genotype frequency increased from AA to AT to TT in both macrovascular (CVD) and microvascular complications (retinopathy, nephropathy, and neuropathy). Moreover, risk allele(A) was also significantly contributed to CVD (=0.001), retinopathy (=0.004), nephropathy (=0.001), and neuropathy (=0.002). AA genotype of the FTO gene rs9939609 showed the tendency to increase the risk of CVD (OR, 1.21; 95% CI, 1.07-1.70; =0.04) and retinopathy (OR, 1.18; 95% CI, 1.02-1.87; =0.001) while no significant changes were recorded in diabetic nephropathy (OR,1.56; 95%CI,1.2-2.43; =0.67) and neuropathy (OR, 2.49; 95%, 1.52-4.1; =0.06).

Conclusion

Our data indicate that the FTO gene variant rs9939609 is linked to an elevated risk of both microvascular & macrovascular complications in individuals with T2DM.

© 2026 The Author(s). Published by Bentham Science Publishers.
This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cdr/10.2174/0115733998343753250226081545
2025-04-10
2026-02-23

  • From This Site

    /content/journals/cdr/10.2174/0115733998343753250226081545
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cdr/22/2/CDR-22-2-05.html?itemId=/content/journals/cdr/10.2174/0115733998343753250226081545&mimeType=html&fmt=ahah

References

  1. SaeediP. PetersohnI. SalpeaP. MalandaB. KarurangaS. UnwinN. ColagiuriS. GuariguataL. MotalaA.A. OgurtsovaK. ShawJ.E. BrightD. WilliamsR. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes atlas, 9th edition.Diabetes Res. Clin. Pract.201915710784310.1016/j.diabres.2019.10784331518657
     [Google Scholar]
  2. WolfR.M. NagpalM. MaggeS.N. Diabetes and cardiometabolic risk in South Asian youth: A review.Pediatr. Diabetes2021221526610.1111/pedi.1307832666595
     [Google Scholar]
  3. SunH. SaeediP. KarurangaS. PinkepankM. OgurtsovaK. DuncanB.B. SteinC. BasitA. ChanJ.C.N. MbanyaJ.C. PavkovM.E. RamachandaranA. WildS.H. JamesS. HermanW.H. ZhangP. BommerC. KuoS. BoykoE.J. MaglianoD.J. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.Diabetes Res. Clin. Pract.202218310911910.1016/j.diabres.2021.10911934879977
     [Google Scholar]
  4. LingW. HuangY. HuangY.M. FanR.R. SuiY. ZhaoH.L. Global trend of diabetes mortality attributed to vascular complications, 2000–2016.Cardiovasc. Diabetol.202019118210.1186/s12933‑020‑01159‑533081808
     [Google Scholar]
  5. KanayaA.M. Diabetes in South Asians: Uncovering novel risk factors with longitudinal epidemiologic data: Kelly West Award Lecture 2023.Diabetes Care202447171610.2337/dci23‑006838117990
     [Google Scholar]
  6. van NielJ. Geelhoed-DuijvestijnP.H.L.M. NumansM.E. KharagjitsinghA.V. VosR.C. Type 2 diabetes in South Asians compared to Europeans: Higher risk and earlier development of major cardiovascular events irrespective of the presence and degree of retinopathy. Results from The Hindu the hague diabetes study.Endocrinol. Diabetes Metab.202143e0024210.1002/edm2.24234277967
     [Google Scholar]
  7. RomanG Pantea StoianA. 2021Cardiovascular risk/disease in type 2 diabetes mellitus. Type 2 diabetes: from pathophysiology to cyber systems2021277Intech open10.5772/intechopen.87312
     [Google Scholar]
  8. YunJ.S. KoS.H. Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes.Metabolism202112315483810.1016/j.metabol.2021.15483834333002
     [Google Scholar]
  9. SwamyS. NoorS.M. MathewR.O. Cardiovascular disease in diabetes and chronic kidney disease.J. Clin. Med.20231222698410.3390/jcm1222698438002599
     [Google Scholar]
  10. ArnoldS.V. KhuntiK. TangF. ChenH. Cid-RuzafaJ. CooperA. FeniciP. GomesM.B. HammarN. JiL. SaraivaG.L. MedinaJ. NicolucciA. RamirezL. RathmannW. ShestakovaM.V. ShimomuraI. SurmontF. VoraJ. WatadaH. KosiborodM. Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.Am. Heart J.202224323223910.1016/j.ahj.2021.10.18134666013
     [Google Scholar]
  11. RothG.A. MensahG.A. FusterV. The global burden of cardiovascular diseases and risks: A compass for global action.J. Am. Coll. Cardiol.202076252980298110.1016/j.jacc.2020.11.02133309174
     [Google Scholar]
  12. GaluškaD. DlouháL. HubáčekJ.A. KaňkováK. Genetics of T2DM and its chronic complications: Are we any closer to the individual prediction of genetic risk?Folia Biol.2022685-615917910.14712/fb202206805015937256551
     [Google Scholar]
  13. YahayaT.O. SalisuT.F. A review of type 2 diabetes mellitus predisposing genes.Curr. Diabetes Rev.2019161526110.2174/157339981566618120414580630514191
     [Google Scholar]
  14. HuangC. ChenW. WangX. Studies on the fat mass and obesity-associated (FTO) gene and its impact on obesity-associated diseases.Genes Dis.20231062351236510.1016/j.gendis.2022.04.01437554175
     [Google Scholar]
  15. KucherA.N. The FTO gene and diseases: The role of genetic polymorphism, epigenetic modifications, and environmental factors.Russ. J. Genet.20205691025104310.1134/S1022795420090136
     [Google Scholar]
  16. AlrajhiH.I. AlmutairiA.B. AlrowayehH.N. The influence of fat mass and obesity-associated (FTO) gene on the effect of physical activity (PA) on risk of obesity: Scoping review.J. Sci. Sport Exerc.20235319320210.1007/s42978‑022‑00206‑9
     [Google Scholar]
  17. MehrdadM. DoaeiS. GholamalizadehM. EftekhariM.H. The association between FTO genotype with macronutrients and calorie intake in overweight adults.Lipids Health Dis.202019119710.1186/s12944‑020‑01372‑x32843047
     [Google Scholar]
  18. WangD. WuZ. ZhouJ. ZhangX. Rs9939609 polymorphism of the fat mass and obesity-associated (FTO) gene and metabolic syndrome susceptibility in the Chinese population: a meta-analysis.Endocrine202069227828510.1007/s12020‑020‑02280‑x32303904
     [Google Scholar]
  19. AliA.H.A. ShkuratT.P. AbbasA.H. Association analysis of FTO gene polymorphisms rs9939609 and obesity risk among the adults: A systematic review and meta-analysis.Meta Gene20212710083210.1016/j.mgene.2020.100832
     [Google Scholar]
  20. HuongP.T. NguyenC.T.T. NhungV.T. The association between FTO polymorphisms and type 2 diabetes in Asian populations: A meta-analysis.Meta Gene20213010095810.1016/j.mgene.2021.100958
     [Google Scholar]
  21. ChenY. DuX. KuppaA. FeitosaM.F. BielakL.F. O’ConnellJ.R. MusaniS.K. GuoX. KahaliB. ChenV.L. SmithA.V. RyanK.A. EirksdottirG. AllisonM.A. BowdenD.W. BudoffM.J. CarrJ.J. ChenY.D.I. TaylorK.D. OliveriA. CorreaA. CrudupB.F. KardiaS.L.R. MosleyT.H.Jr NorrisJ.M. TerryJ.G. RotterJ.I. WagenknechtL.E. HalliganB.D. YoungK.A. HokansonJ.E. WashkoG.R. GudnasonV. ProvinceM.A. PeyserP.A. PalmerN.D. SpeliotesE.K. Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease.Nat. Genet.202355101640165010.1038/s41588‑023‑01497‑637709864
     [Google Scholar]
  22. XuZ.Y. JingX. XiongX.D. Emerging role and mechanism of the FTO gene in cardiovascular diseases.Biomolecules202313585010.3390/biom1305085037238719
     [Google Scholar]
  23. VrablikM. DlouhaD. TodorovovaV. SteflerD. HubacekJ.A. Genetics of cardiovascular disease: How far are we from personalized CVD risk prediction and management?Int. J. Mol. Sci.2021228418210.3390/ijms2208418233920733
     [Google Scholar]
  24. MukhopadhyayS. DixitP. KhanomN. SangheraG. McGurkK.A. The genetic factors influencing cardiomyopathies and heart failure across the allele frequency spectrum.J. Cardiovasc. Transl. Res.20241751119113910.1007/s12265‑024‑10520‑y38771459
     [Google Scholar]
  25. RehmanK. NiazS. TahirA. JabeenK. AkashM.S.H. FTO, PPAR-γ and ABCC8 gene variation and hypertension as determinants of cardiometabolic risk in CVD patients.Metabolism202212815497210.1016/j.metabol.2021.154972
     [Google Scholar]
  26. LanN. LuY. ZhangY. PuS. XiH. NieX. LiuJ. YuanW. FTO–a common genetic basis for obesity and cancer.Front. Genet.20201155913810.3389/fgene.2020.55913833304380
     [Google Scholar]
  27. KhanS. VermaA.K. KhanV. BhattD. RafatS. AlsahliM.A. RahmaniA.H. MeenaB. NaqviI.H. DevK. Role of FTO and MC4R polymorphisms in escalating obesity and their indirect association with risk of T2D in Indian population.Diabetes Ther.20201192145215710.1007/s13300‑020‑00896‑w32740722
     [Google Scholar]
  28. SabryJ.H. IbrahimM.E. El FadeelS.A. El-FallahA.A. Study of FTO gene polymorphism association with type 2 diabetes and increasing BMI in egyptian patients.Benha Journal of Applied Sciences2020551910.21608/bjas.2020.136647
     [Google Scholar]
  29. IkhanjalMA ElouaridMA ZouineC ErrafiiK GhazalH AlidrissiN FTO gene variants (rs9939609, rs8050136 and rs17817449) and type 2 diabetes mellitus risk: A meta-analysis.Gene202388714779110.1016/j.gene.2023.147791
     [Google Scholar]
  30. HeD. FuM. MiaoS. HottaK. ChandakG.R. XiB. FTO gene variant and risk of hypertension: A meta-analysis of 57, 464 hypertensive cases and 41, 256 controls.Metabolism201463563363910.1016/j.metabol.2014.02.00824641884
     [Google Scholar]
  31. HussainM. WaheedA. ElahiA. MustafaG. Fat mass and obesity-related (FTO) gene variant is a predictor of CVD in T2DM patients.J. Diabetes Res.202420241591431610.1155/2024/591431639257882
     [Google Scholar]
  32. OlzaJ. RuperezA.I. Gil-CamposM. LeisR. Fernandez-OrthD. TojoR. CañeteR. GilA. AguileraC.M. Influence of FTO variants on obesity, inflammation and cardiovascular disease risk biomarkers in Spanish children: a case–control multicentre study.BMC Med. Genet.201314112310.1186/1471‑2350‑14‑12324289790
     [Google Scholar]
  33. AbolnezhadianF. HosseiniS.A. AlipourM. ZakerkishM. CheraghianB. GhandilP. CheraghpourM. Association metabolic obesity phenotypes with cardiometabolic index, atherogenic index of plasma and novel anthropometric indices: a link of FTO-rs9939609 polymorphism.Vasc. Health Risk Manag.20201624925610.2147/VHRM.S25192732612360
     [Google Scholar]
  34. American Diabetes Association Classification and diagnosis of diabetes: standards of medical care in diabetes—2021.Diabetes Care202144Suppl. 1S15S3310.2337/dc21‑S00233298413
     [Google Scholar]
  35. JanA. WeirC.B. BMI classification percentile and cut off points.Treasure Island, FL, USAStat Pearls202114
     [Google Scholar]
  36. GuidelineA.D.A. American diabetes association glycemic targets: Standards of medical care in diabetes—2020.Diabetes Care202043Suppl. 1S66S7610.2337/dc20‑S00631862749
     [Google Scholar]
  37. DoneyA.S.F. DannfaldJ. KimberC.H. DonnellyL.A. PearsonE. MorrisA.D. PalmerC.N.A. The FTO gene is associated with an atherogenic lipid profile and myocardial infarction in patients with type 2 diabetes: A genetics of diabetes audit and research study in tayside Scotland (Go-DARTS) study.Circ. Cardiovasc. Genet.20092325525910.1161/CIRCGENETICS.108.82232020031593
     [Google Scholar]
  38. LappalainenT. KolehmainenM. SchwabU.S. TolppanenA.M. StančákováA. LindströmJ. ErikssonJ.G. Keinänen-KiukaanniemiS. AunolaS. Ilanne-ParikkaP. HerderC. KoenigW. GyllingH. KolbH. TuomilehtoJ. KuusistoJ. UusitupaM. Finnish Diabetes Prevention Study Group Association of the FTO gene variant (rs9939609) with cardiovascular disease in men with abnormal glucose metabolism – The finnish diabetes prevention study.Nutr. Metab. Cardiovasc. Dis.201121969169810.1016/j.numecd.2010.01.00620400278
     [Google Scholar]
  39. ShahidS.U. Shabana RehmanA. HasnainS. Role of a common variant of Fat Mass and Obesity associated (FTO) gene in obesity and coronary artery disease in subjects from Punjab, Pakistan: a case control study.Lipids Health Dis.20161512910.1186/s12944‑016‑0200‑0
     [Google Scholar]
  40. LeeJ.S. ChangP.Y. ZhangY. KizerJ.R. BestL.G. HowardB.V. Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: the strong heart study.Diabetes Care201740452953710.2337/dc16‑195828122840
     [Google Scholar]
  41. KosmasC.E. Rodriguez PolancoS. BousvarouM.D. PapakonstantinouE.J. Peña GenaoE. GuzmanE. KostaraC.E. The triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio as a risk marker for metabolic syndrome and cardiovascular disease.Diagnostics (Basel)202313592910.3390/diagnostics1305092936900073
     [Google Scholar]
  42. MehrdadM. FardaeiM. FararoueiM. EftekhariM.H. The association between FTO rs9939609 gene polymorphism and anthropometric indices in adults.J. Physiol. Anthropol.20203911410.1186/s40101‑020‑00224‑y32398148
     [Google Scholar]
  43. JaliliV. MokhtariZ. RastgooS. HajipourA. BourbourF. GholamalizadehM. Mosavi JarrahiA. JavadiKoosheshS. MoslemA. AbdollahiM. DoaeiS. The association between FTO rs9939609 polymorphism and serum lipid profile in adult women.Diabetol. Metab. Syndr.202113113810.1186/s13098‑021‑00754‑034801066
     [Google Scholar]
  44. KhellaM.S. HamdyN.M. AminA.I. El-MesallamyH.O. The (FTO) gene polymorphism is associated with metabolic syndrome risk in Egyptian females: a case- control study.BMC Med. Genet.201718110110.1186/s12881‑017‑0461‑028915859
     [Google Scholar]
  45. FranczakA. KolačkovK. Jawiarczyk-PrzybyłowskaA. BolanowskiM. Association between FTO gene polymorphisms and HDL cholesterol concentration may cause higher risk of cardiovascular disease in patients with acromegaly.Pituitary2018211101510.1007/s11102‑017‑0840‑828913579
     [Google Scholar]
  46. QureshiS.A. MumtazA. ShahidS.U. ShabanaN.A. rs3751812, a common variant in fat mass and obesity-associated (FTO) gene, is associated with serum high- and low-density lipoprotein cholesterol in Pakistani individuals.Nutrition201739-40929510.1016/j.nut.2016.04.00827324062
     [Google Scholar]
  47. HashimM.F. SabahF.S. AbbasH.J. Study the association of fat mass and obesity-associated (FTO) gene polymorphisms (SNP rs9939609) with biochemical markers in obese iraqi patients.Iraqi J. Sci.202465268469210.24996/ijs.2024.65.2.9
     [Google Scholar]
  48. ShahidS.U. Shabana CooperJ.A. BeaneyK.E. LiK. RehmanA. HumphriesS.E. Genetic risk analysis of coronary artery disease in Pakistani subjects using a genetic risk score of 21 variants.Atherosclerosis20172581710.1016/j.atherosclerosis.2017.01.02428167353
     [Google Scholar]
  49. WangY. WangY. GuJ. SuT. GuX. FengY. The role of RNA m6A methylation in lipid metabolism.Front. Endocrinol. (Lausanne)20221386611610.3389/fendo.2022.86611636157445
     [Google Scholar]
  50. ÄijäläM. RonkainenJ. HuuskoT. MaloE. SavolainenE.R. SavolainenM.J. SalonurmiT. BloiguR. Antero KesäniemiY. UkkolaO. The fat mass and obesity-associated (FTO) gene variant rs9939609 predicts long-term incidence of cardiovascular disease and related death independent of the traditional risk factors.Ann. Med.201547865566310.3109/07853890.2015.109108826555680
     [Google Scholar]
  51. HubacekJ.A. StaněkV. GebauerováM. PilipčincováA. DlouháD. PoledneR. AschermannM. SkalickáH. MatouškováJ. KrugerA. PěničkaM. HrabákováH. VeselkaJ. HájekP. LánskáV. AdámkováV. PiťhaJ. A FTO variant and risk of acute coronary syndrome.Clin. Chim. Acta201041115-161069107210.1016/j.cca.2010.03.03720362563
     [Google Scholar]
  52. GustavssonJ. MehligK. LeanderK. LissnerL. BjörckL. RosengrenA. NybergF. FTO genotype, physical activity, and coronary heart disease risk in Swedish men and women.Circ. Cardiovasc. Genet.20147217117710.1161/CIRCGENETICS.111.00000724622111
     [Google Scholar]
  53. LiuC. MouS. PanC. The FTO gene rs9939609 polymorphism predicts risk of cardiovascular disease: A systematic review and meta-analysis.PLoS One201388e7190110.1371/journal.pone.007190123977173
     [Google Scholar]
  54. HubacekJ.A. DlouhaD. KlementovaM. LanskaV. NeskudlaT. PelikanovaT. The FTO variant is associated with chronic complications of diabetes mellitus in Czech population.Gene201864222022410.1016/j.gene.2017.11.04029154870
     [Google Scholar]
  55. Masoud Abd El GayedE. Kamal El Din ZewainS. RaghebA. ElNaidanyS.S. Fat mass and obesity-associated gene expression and disease severity in type 2 diabetes mellitus.Steroids202117410889710.1016/j.steroids.2021.10889734358558
     [Google Scholar]
  56. WangQ. WangJ. LinH. HuoX. ZhuQ. ZhangM. Relationship between fat mass and obesity-associated gene expression and type 2 diabetes mellitus severity.Exp. Ther. Med.20181532917292110.3892/etm.2018.575229456697
     [Google Scholar]
  57. TairaM. ImamuraM. TakahashiA. KamataniY. YamauchiT. ArakiS. TanakaN. van ZuydamN.R. AhlqvistE. ToyodaM. UmezonoT. KawaiK. ImanishiM. WatadaH. SuzukiD. MaegawaH. BabazonoT. KakuK. KawamoriR. GroopL.C. McCarthyM.I. KadowakiT. MaedaS. A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.PLoS One20181312e020865410.1371/journal.pone.020865430566433
     [Google Scholar]
  58. MarchettiJ. BalbinoK.P. HermsdorffH.H.M. JuvanholL.L. MartinezJ.A. SteemburgoT. Relationship between the FTO genotype and early chronic kidney disease in type 2 diabetes: the mediating role of central obesity, hypertension, and high albuminuria.Lifestyle Genomics2021143738010.1159/00051611834134115
     [Google Scholar]
  59. HsiaoY.T. ShenF.C. WengS.W. WangP.W. ChenY.J. LeeJ.J. Multiple single nucleotide polymorphism testing improves the prediction of diabetic retinopathy risk with type 2 diabetes mellitus.J. Pers. Med.202111868910.3390/jpm1108068934442333
     [Google Scholar]
  60. MontesantoA. BonfigliA.R. CroccoP. GaragnaniP. De LucaM. BoemiM. MarascoE. PirazziniC. GiulianiC. FranceschiC. PassarinoG. TestaR. OlivieriF. RoseG. Genes associated with Type 2 Diabetes and vascular complications.Aging201810217819610.18632/aging.10137529410390
     [Google Scholar]
  61. HubacekJA DlouhaL AdamkovaV DlouhaD PacalL KankovaK Genetic risk score is associated with T2DM and diabetes complications risks.Gene202384914692110.1016/j.gene.2022.146921
     [Google Scholar]
/content/journals/cdr/10.2174/0115733998343753250226081545
Loading
FTO Gene rs9939609 is Potentially Associated with Diabetes Related Complications in T2DM Patients
Curr. Diabetes Rev. 22, E15733998343753 (2026); https://doi.org/10.2174/0115733998343753250226081545
/content/journals/cdr/10.2174/0115733998343753250226081545
/content/journals/cdr/10.2174/0115733998343753250226081545
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): blood pressure; diabetes complications; FTO; HbA1C; lipid profile; SNP; T2DM

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test